Health Care • Hospital/Nursing Management
$23.21 ▲ +0.00
(0.00%)
MKT CAP: $3.04B • VOL: 3.51M
52W L $11 52W H $23
SGRY // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $0 | $0 | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | $0 | $0 | $0 |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $389.5M | $348.8M | $328.0M |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | -$77.9M | -$168.1M | -$11.9M |
| EBITDA (Normalized) | $452.5M | $421.1M | $328.0M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $274.3M | $300.1M | $293.8M |
| Capital Expenditures (CapEx) | $78.7M | $90.4M | $0 |
| Free Cash Flow (FCF) | $195.6M | $209.7M | $293.8M |
| FCF Margin % | — | — | — |
| Return on Invested Capital (ROIC %) | 9.1% | 8.2% | 25.7% |
| Cash & Short-Term Equivalents | $239.9M | $269.5M | — |
| Total Debt (Short + Long Term) | $1.90B | $1.85B | $391.1M |
| Total Stockholders' Equity | $1.71B | $1.79B | $802.2M |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR SGRY.